180 related articles for article (PubMed ID: 9305898)
1. Direct identification of a distinct site of interaction between the carboxyl-terminal residue of cholecystokinin and the type A cholecystokinin receptor using photoaffinity labeling.
Ji Z; Hadac EM; Henne RM; Patel SA; Lybrand TP; Miller LJ
J Biol Chem; 1997 Sep; 272(39):24393-401. PubMed ID: 9305898
[TBL] [Abstract][Full Text] [Related]
2. Direct identification of a second distinct site of contact between cholecystokinin and its receptor.
Hadac EM; Pinon DI; Ji Z; Holicky EL; Henne RM; Lybrand TP; Miller LJ
J Biol Chem; 1998 May; 273(21):12988-93. PubMed ID: 9582333
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic photoaffinity labeling probes for cholecystokinin (CCK)-gastrin family receptors. D-Tyr-Gly-[Nle28,31,pNO2-Phe33)CCK-26-33).
Powers SP; Fourmy D; Gaisano H; Miller LJ
J Biol Chem; 1988 Apr; 263(11):5295-300. PubMed ID: 2451666
[TBL] [Abstract][Full Text] [Related]
4. Refinement of the structure of the ligand-occupied cholecystokinin receptor using a photolabile amino-terminal probe.
Ding XQ; Dolu V; Hadac EM; Holicky EL; Pinon DI; Lybrand TP; Miller LJ
J Biol Chem; 2001 Feb; 276(6):4236-44. PubMed ID: 11050076
[TBL] [Abstract][Full Text] [Related]
5. A peptide agonist acts by occupation of a monomeric G protein-coupled receptor: dual sites of covalent attachment to domains near TM1 and TM7 of the same molecule make biologically significant domain-swapped dimerization unlikely.
Hadac EM; Ji Z; Pinon DI; Henne RM; Lybrand TP; Miller LJ
J Med Chem; 1999 Jun; 42(12):2105-11. PubMed ID: 10377216
[TBL] [Abstract][Full Text] [Related]
6. Direct identification of the agonist binding site in the human brain cholecystokininB receptor.
Anders J; Blüggel M; Meyer HE; Kühne R; ter Laak AM; Kojro E; Fahrenholz F
Biochemistry; 1999 May; 38(19):6043-55. PubMed ID: 10320330
[TBL] [Abstract][Full Text] [Related]
7. Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling.
Dong M; Lam PC; Pinon DI; Abagyan R; Miller LJ
Biochemistry; 2009 Jun; 48(23):5303-12. PubMed ID: 19441839
[TBL] [Abstract][Full Text] [Related]
8. Structurally related peptide agonist, partial agonist, and antagonist occupy a similar binding pocket within the cholecystokinin receptor. Rapid analysis using fluorescent photoaffinity labeling probes and capillary electrophoresis.
Dong M; Ding XQ; Pinon DI; Hadac EM; Oda RP; Landers JP; Miller LJ
J Biol Chem; 1999 Feb; 274(8):4778-85. PubMed ID: 9988716
[TBL] [Abstract][Full Text] [Related]
9. Direct demonstration of unique mode of natural peptide binding to the type 2 cholecystokinin receptor using photoaffinity labeling.
Dong M; Miller LJ
Peptides; 2013 Aug; 46():143-9. PubMed ID: 23770253
[TBL] [Abstract][Full Text] [Related]
10. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
Arlander SJ; Dong M; Ding XQ; Pinon DI; Miller LJ
Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
[TBL] [Abstract][Full Text] [Related]
11. Identification of an interaction between residue 6 of the natural peptide ligand and a distinct residue within the amino-terminal tail of the secretin receptor.
Dong M; Wang Y; Hadac EM; Pinon DI; Holicky E; Miller LJ
J Biol Chem; 1999 Jul; 274(27):19161-7. PubMed ID: 10383421
[TBL] [Abstract][Full Text] [Related]
12. Differential docking of high-affinity peptide ligands to type A and B cholecystokinin receptors demonstrated by photoaffinity labeling.
Dong M; Liu G; Pinon DI; Miller LJ
Biochemistry; 2005 May; 44(17):6693-700. PubMed ID: 15850403
[TBL] [Abstract][Full Text] [Related]
13. Photoaffinity labeling of rat pancreatic cholecystokinin type A receptor antagonist binding sites demonstrates the presence of a truncated cholecystokinin type A receptor.
Poirot SS; Escrieut C; Dufresne M; Martinez J; Bouisson M; Vaysse N; Fourmy D
Mol Pharmacol; 1994 Apr; 45(4):599-607. PubMed ID: 8183238
[TBL] [Abstract][Full Text] [Related]
14. A new probe for affinity labelling pancreatic cholecystokinin receptor with minor modification of its structure.
Fourmy D; Lopez P; Poirot S; Jimenez J; Dufresne M; Moroder L; Powers SP; Vaysse N
Eur J Biochem; 1989 Nov; 185(2):397-403. PubMed ID: 2583188
[TBL] [Abstract][Full Text] [Related]
15. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
Harikumar KG; Pinon DI; Wessels WS; Dawson ES; Lybrand TP; Prendergast FG; Miller LJ
Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
[TBL] [Abstract][Full Text] [Related]
16. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
17. Use of a nitrotryptophan-containing peptide for photoaffinity labeling the pancreatic cholecystokinin receptor.
Klueppelberg UG; Gaisano HY; Powers SP; Miller LJ
Biochemistry; 1989 Apr; 28(8):3463-8. PubMed ID: 2742849
[TBL] [Abstract][Full Text] [Related]
18. Affinity labeling the bovine gallbladder cholecystokinin receptor using a battery of probes.
Schjoldager B; Powers SP; Miller LJ
Am J Physiol; 1988 Nov; 255(5 Pt 1):G579-86. PubMed ID: 3056035
[TBL] [Abstract][Full Text] [Related]
19. Refinement of the conformation of a critical region of charge-charge interaction between cholecystokinin and its receptor.
Ding XQ; Pinon DI; Furse KE; Lybrand TP; Miller LJ
Mol Pharmacol; 2002 May; 61(5):1041-52. PubMed ID: 11961122
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of agonist binding to the type A cholecystokinin receptor.
Miller LJ; Lybrand TP
Pharmacol Toxicol; 2002 Dec; 91(6):282-5. PubMed ID: 12688369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
